Browsing Tag
Mayne Pharma Group Limited
3 posts
Can pharma M&A survive Australia’s new national interest doctrine?
Australia’s FIRB blocked Cosette’s $430M takeover of Mayne Pharma. Can foreign pharma buyers still close deals in this new national interest era?
Australia kills Cosette’s Mayne Pharma (ASX: MYX) buyout—citing drug supply risk and sovereignty
Australia blocks Cosette’s $430M bid to acquire Mayne Pharma, citing critical medicine supply risks. Find out what triggered the decision and future implications.
ASX top losers today: Mayne Pharma, Nufarm, E79 Gold lead market declines
Mayne Pharma and Nufarm led ASX losses on May 21, 2025, amid sector-wide sell-offs in mining, biotech, and tech. Find out what drove the declines.